The largest database of trusted experimental protocols

Anti vim

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Anti-VIM is a laboratory antibody product used for the detection of Vimentin (VIM) protein in biological samples. VIM is a type III intermediate filament protein involved in maintaining cell structure and integrity. The Anti-VIM product can be utilized in various research and diagnostic applications that require the identification and quantification of VIM expression.

Automatically generated - may contain errors

10 protocols using anti vim

1

Immunofluorescence Staining of Cytoskeletal Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used in this study include mouse monoclonal anti-CK8 (1/200 dilution) (Covance, CA), rabbit polyclonal anti-Vim (1/50 dilution) (Santa Cruz Biotechnology, CA), Alexa 488 goat anti-rabbit, and Alexa 568 goat anti-mouse (Invitrogen, CA). All secondary Alexa Fluor antibodies were used at 1/200 dilution. Fluoro-gel II with DAPI (Electron Microscopy Sciences, PA) was used for mounting.
+ Open protocol
+ Expand
2

Smad4 Variant Expression and E-cadherin/Vimentin Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The A549 cells stably expressed wildtype Smad4 and its variants, which were used for the Western blot experiments. Collect and lyse cells with RIPA buffer for 30 min on ice. Total protein lysis was used to measure target protein expression. The anti-E-cad (Santa Cruz, Cat#sc-8426) and anti-VIM (Santa Cruz, Cat#sc-373717) antibodies were purchased from Santa Cruz. The anti-GAPDH (Cat#10494-1-AP) and Smad4 (Cat#10231-1-AP) antibodies were purchased from Proteintech. Load 30 μg total protein into 10% SDS-PAGE gel and run for 90 min at 120 V. Transfer the gel on the PVDF membrane and then incubate with 5% nonfat milk for 30 min by slowly shaking at room temperature. We then incubated the primary antibodies at 4°C in a freezer overnight and washed with TBST for 10 min, repeating 3 times. The secondary antibodies were then incubated at room temperature for 1 h by slowly shaking. The images of membrane were taken with a standard chemiluminescence.
+ Open protocol
+ Expand
3

Inhibition of TGF-β Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human recombinant TGF-β1 was obtained from R&D Systems (Minneapolis, MN). The TGF-β RI (TβRI) kinase inhibitor SB431542 was obtained from Millipore (Billerica, MA), and SD-208 was purchased from Sigma (St Louis, MO). The following antibodies were used in this study: anti-PPM1A, anti-MMP2, anti-MMP9, anti-Smad2, anti-Smad3, anti-phosphorylated Smad2 and anti-phosphorylated Smad3 (Cell Signaling Technology, Beverly, MA) as well as anti-E-cadherin, anti-GAPDH, anti-CK19, anti-phosphorylated Smad2/3 and anti-Vim (Santa Cruz, CA, USA). SB431542 was applied during the TGF-β1 perfusion.
+ Open protocol
+ Expand
4

Western Blot Analysis of Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at equal densities in complete media and the media exchanged 24 h later for EGF-free media +/− inhibitor for an additional 24 h growth. Cells were scraped into 1X PBS and lysed in RIPA buffer containing 1 mM PMSF (Sigma), 1 mM Na3VO4 (Sigma) and 1x cOmplete Protease Inhibitor cocktail (PI) (Roche, Indianapolis, IN, USA). Twenty milligrams protein was resolved by SDS-PAGE using NuPAGE 4–12% Bis-Tris protein gels (Life Technologies), transferred onto PVDF (Millipore, Billerica, MA, USA) and blocked in 5% BSA. Following overnight blotting with primary antibody, protein was detected by ECL using horseradish peroxidase-conjugated secondary antibodies (Sigma). Primary antibodies used in this study are: anti-RAS (#3965), anti-phospho-p44/42 MAPK (ERK1/2) (Thr202/Tyr204) (#4370S), anti-p44/42 MAPK (ERK1/2) (#4696), anti-PI3K p110α (#4255), anti-phospho-AKT (Ser473) (#4051), anti-AKT (#4685), anti-C-MYC (#9402), anti-NDRG1 (#5196), anti-GAPDH (#2118) (Cell Signaling Technologies, Danvers, MA, USA), anti-BRD9 (#A303-781A, Bethyl Laboratories, Montgomery, TX, USA), anti-BRG1 (#sc-17796) and anti-VIM (#sc-6260) (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
+ Open protocol
+ Expand
5

Comprehensive Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Co-immunoprecipitation and subsequent Western blotting was performed as described previously (15 ). Antibodies include: anti-ERG (ab92513, Abcam; CM421C, Biocare Medical), anti-PTEN (CST9559L, Cell Signaling Technology), anti-p53 (sc126, Santa Cruz Biotechnology), anti-AR (sc816, Santa Cruz Biotechnology), anti-NKX3.1 (NB100-1828, Novus Biologicals), anti-RB (554136, BD Biosciences), anti-pRB S795 (CST9301S, Cell Signaling Technology), anti-SKP2 (32-3300, Life Technologies), anti-CCND1 (sc718, Santa Cruz Biotechnology), anti-CDK1 (sc54, Santa Cruz Biotechnology), anti-TWIST (sc6269, Santa Cruz Biotechnology), anti-CDH1 (610181, BD Biosciences), anti-VIM (sc73258, Santa Cruz Biotechnology), anti-ERK2 (sc1647, Santa Cruz Biotechnology), anti-CDK2 (sc6248, Santa Cruz Biotechnology), anti-E2F1 (sc193, Santa Cruz Biotechnology), anti-pAKT S473 (CST4060L, Cell Signaling Technology), anti-AKT (CST9272, Cell Signaling Technology).
+ Open protocol
+ Expand
6

Immunofluorescence Staining Protocol for Protein Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunofluorescence staining was performed using a similar protocol to the one described previously (Chau et al., 2014 (link)). The primary antibodies used in this study were anti-WT1 (Abcam, ab89901, 1:1000), anti-Ki67 (Abcam, ab15580, 1:1000), anti-GFP (Abcam, ab5450, 1:1000), anti-PAX2 (Biolegend, 901001, 1:100), anti-MF20 (DSHB, Ab_2147781, 1:20), anti-VIM (Santa Cruz Biotechnology, sc-7557, 1:100), anti-CDH1 (BD, 610181, 1:100), anti-RALDH2 (Santa Cruz Biotechnology, sc-22591, 1:200), anti-GATA4 (Santa Cruz Biotechnology, sc-25310, 1:100), anti-TCF4 (Cell Signaling Technology, C48H11, 1:100) and anti-MYOD (Santa Cruz Biotechnology, sc-32758, 1:100). Alexa-Fluor 488- or 594-conjugated antibodies were used as secondary antibodies. Sections were stained with 4′,6-diamidino-2-phenylindole (DAPI) and mounted using VectorShield. A Zeiss Axioplan II microscope was used to view immunofluorescence and H&E-stained sections. Image capture was performed using the open source microscopy software: uManager.
+ Open protocol
+ Expand
7

Multicellular Protein Expression Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were incubated with anti-panCK (1:200, sc-8018; Santa Cruz, CA), anti-VIM (1:500, sc-6260; Santa Cruz), anti-ASMA (1:200, A5228; Sigma, MA), and anti-FAP (1:100, ab53066; Abcam, Cambridge, UK) at RT for 3 h. The anti-mouse IgG-Cy3 (1:2,000, 115-166-071; Jackson ImmunoResearch Laboratories, PA) or anti-rabbit IgG-FITC (1:2,000, ab6717; Abcam) was applied at RT for 1 h. The anti-CD10-FITC (1:5, 21270103; Invitrogen, Thermo Fisher Scientific, MA) and anti-GPR77 (1:30, 342402; Biolegend, CA) were incubated with cells at 4°C overnight. The nuclei were stained with Hoechst dye (1:1,000; Invitrogen). The fluorescence signals were captured with a confocal microscope (LSM800, Carl Zeiss Microscopy, Jena, Germany).
+ Open protocol
+ Expand
8

Antibody Panel for Cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies used include: NOTCH4 receptor (1:200 dilution, Millipore), anti-CK18 (1:200 dilution, Abcam), anti-K-5 and anti-K14 (1:200 dilution, Covance), anti-CDH1 and anti-VIM (1:50, Santa Cruz Biotechnology).
+ Open protocol
+ Expand
9

Western Blot Analysis of Endothelial Cell Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated ECs of mouse aortae, mouse aortae (whole, TA and AA), human ECs (HUVECs and HAECs) and human renal arteries were homogenized in ice-cold 1X RIPA lysis buffer supplemented with Complete Protease Inhibitor cocktail (Sigma-Aldrich) and phosSTOP phosphatase inhibitor (Roche, Basel, Switzerland). Protein concentrations were determined by a BCA protein assay kit (Pierce Biotechnology, Rockford, USA). Equal amount of proteins were loaded and resolved by a 10% SDS-polyacrylamide gel and transferred onto an Immobilon-P polyvinylidene difluoride membrane (Millipore Corp., Bedford, MA, USA). Nonspecific binding sites were blocked by 3% BSA in TBS containing 0.05% Tween-20. The blots were incubated overnight at 4 °C with primary antibodies: anti-SOX4 (1:200; sc-130633; Santa Cruz Biotechnology, Texas, USA), anti-eNOS (1:1000; 610297; BD Transduction Laboratory, San Diego, USA), anti-PECAM-1 (1:500; sc-1506-R; Santa Cruz Biotechnology), anti-VIM (1:500; sc-6260; Santa Cruz Biotechnology) and anti-GAPDH (1:1000; 2118S; Cell Signaling Technology, Massachusetts, USA). Bound antibodies were incubated with horseradish peroxidase-conjugated secondary antibodies (Cell Signaling Technology) at room temperature for 1 h. Protein bands were later visualized by enhanced chemiluminescence (Cell Signaling Technology) with the aid of ChemiDoc™ Imaging System (Bio-Rad).
+ Open protocol
+ Expand
10

Immunocytochemical Analysis of Human Sertoli and Germ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunocytochemical staining, the freshly isolated and cultured human Sertoli cells as well as human male germ cells were fixed with 4% paraformaldehyde (PFA) for 30 min, washed three times with cold phosphate-buffered saline (PBS) and permeabilized in 0.4% triton-X 100 (Sigma) for 5 min. After washing with PBS, the cells were blocked in 2% BSA for 30 min and followed by incubation with primary antibodies, including anti-GATA4 (Santa Cruz), WT1 (Santa Cruz), GDNF (Santa Cruz), anti-SCF (Sigma), anti-BMP4 (Abcam), anti- VIM (Santa Cruz), anti-PCNA (Sigma), anti-SMA (smooth muscle alpha actin, Abcam) and CYP11A1 (cholesterol side-chain cleavage enzyme, Abcam) at a dilution with 1:200 overnight at 4°C. Isotype IgGs for the first antibody were used as the negative controls. After extensive washes with PBS for 30 min, the cells were incubated with the secondary antibody IgG (Sigma) conjugated with fluorescein isothiocyanate (FITC) or rhodamine at a 1:200 dilution for 1 hour at room temperature. DAPI (4,6-diamidino-2-phenylindole) was used to label the nuclei, and the cells were observed for epifluorescence under a fluorescence microscope (Leica).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!